Christian Johana Baños-Hernández

Dr. Christian Johana Baños-Hernández

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ESEric Genaro Salmerón
Eric Genaro Salmerón
AZAna Elvira Zacapala-Gómez
Ana Elvira Zacapala-Gómez
FTFrancisco I. Torres-Rojas
Francisco I. Torres-Rojas
VAVERÓNICA ANTONIO-VÉJAR
VERÓNICA ANTONIO-VÉJAR
PAPedro Avila
Pedro Avila
HJHilda Jiménez-Wences
Hilda Jiménez-Wences
Breast Cancer (BC) was the most common female cancer in incidence and mortality worldwide in 2020. Similarly, BC was the top female cancer in the USA in 2022. Risk factors include earlier age at menarche, oral contraceptive use, hormone replacement therapy, high body mass index, and mutations in BRCA1/2 genes, among others. BC is classified into Luminal A, Luminal B, HER2-like, and Basal-like subtypes. These BC subtypes present differences in gene expression signatures, which can impact clinical behavior, treatment response, aggressiveness, metastasis, and survival of patients. Therefore, it is necessary to understand the epigenetic molecular mechanism of transcriptional regulation in BC, such as DNA demethylation. Ten-Eleven Translocation (TET) enzymes catalyze the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) on DNA, which in turn inhibits or promotes the gene expression. Interestingly, the expression of TET enzymes as well as the levels of the 5hmC epigenetic mark are altered in several types of human cancers, including BC. Several studies have demonstrated that TET enzymes and 5hmC play a key role in the regulation of gene expression in BC, directly (dependent or independent of DNA de-methylation) or indirectly (via interaction with other proteins such as transcription factors). In this review, we describe our recent understanding of the regulatory and physiological function of the TET enzymes, as well as their potential role as biomarkers in BC biology.

14 February 2024 in Genes
Verified
Journal Article
Open access
PDF file
KBKarla Mayela Bravo
Karla Mayela Bravo
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
Christian Johana Baños-HernándezChristian Johana Baños-Hernández
Christian Johana Baños-Hernández
SCSergio Cerpa-Cruz
Sergio Cerpa-Cruz
JNJosé Eduardo Navarro-Zarza
José Eduardo Navarro-Zarza
Andres López-QuinteroAndres López-Quintero
Andres López-Quintero
Rheumatoid Arthritis (RA) is a multifactorial autoimmune disease. Currently, several genes play an important role in the development of the disease. The objective was to evaluate the association of the STAT4 rs7574865 and rs897200 gene variants with RA susceptibility, DAS28, RF, and anti-CCP in Western and Southern Mexico populations. Genotyping was performed on 476 samples (cases = 240; controls = 236) using the Taqman® system and qPCR probes. Disease activity was assessed using DAS28 and HAQ DI. CRP, ESR, RF, and anti-CCP were determined for clinical assessment. Our study showed there is a statistically significant association with susceptibility to RA for the rs7574865 variant in the Western population for the GT and TT genotypes. The same genotypes also showed a moderate-to-high activity according to DAS28 and positive anti-CCP compared to the control group. This association was not found in the Southern population. This work confirms the association of the rs7574865 variant with RA, as well as a moderate-to-high activity and positive anti-CCP in the Western population but not in the Southern population. No association of the rs897200 variant was found in any of the studied populations.

Verified
Journal Article
Open access
PDF file
MFMónica Matuz Flores
Mónica Matuz Flores
JRJesus A Rosas Rodríguez
Jesus A Rosas Rodríguez
OTOrlando Tortoledo-Ortiz
Orlando Tortoledo-Ortiz
Salvador Muñoz-BarriosSalvador Muñoz-Barrios
Salvador Muñoz-Barrios
GMGloria Esther Martínez-Bonilla
Gloria Esther Martínez-Bonilla
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
Citrullination is catalyzed by the peptidyl arginine deiminase 4 (PAD4) enzyme, encoded by the PADI4 gene. Increased PAD4 activity promotes the onset and progression of rheumatoid arthritis (RA). This study aimed to evaluate the association of PADI4 haplotypes with RA risk, mRNA expression, and the PAD4 activity in patients with RA from Mexico. Methodology: 100 RA patients and 100 control subjects (CS) were included. Genotyping was performed by PCR-RFLP method, PADI4 mRNA expression was quantified by real-time PCR, the contribution of PADI4 alleles (PADI4_89 G>A, PADI4_90 T>C, and PADI4_92 G>C) to mRNA expression by the ASTQ method, and PAD4 activity by HPLC. Also, the anti-CCP and anti-PADI4 antibodies were quantified by ELISA. Results: The three PADI4 polymorphisms were associated with RA susceptibility (OR = 1.72, p = 0.005; OR = 1.62; p = 0.014; OR = 1.69; p = 0.009; respectively). The 89G, 90T, and 92G alleles have a higher relative contribution to PADI4 mRNA expression from RA patients than 89A, 90C, and 92C alleles in RA patients. Moreover, the GTG/GTG haplotype was associated with RA susceptibility (OR = 2.86; p = 0.024). The GTG haplotype was associated with higher PADI4 mRNA expression (p = 0.04) and higher PAD4 enzymatic activity (p = 0.007) in RA patients. Conclusions: The evaluated polymorphisms contribute to PADI4 mRNA expression and the enzymatic activity of PAD4 in leukocytes. Therefore, the GTG haplotype is a genetic risk factor for RA in western Mexico, and is associated with increased PADI4 mRNA expression and higher PAD4 activity in these patients.

7 November 2019 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
GSGuillermo Santoscoy-Ascencio
Guillermo Santoscoy-Ascencio
Christian Johana Baños-HernándezChristian Johana Baños-Hernández
Christian Johana Baños-Hernández
JNJosé Eduardo Navarro‐Zarza
José Eduardo Navarro‐Zarza
JHJorge Hernández‐Bello
Jorge Hernández‐Bello
RBRichard Bucala
Richard Bucala
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
Background: Macrophage migration inhibitory factor (MIF) is a cytokine capable of stimulating inflammatory cytokine and matrix metalloproteinase production from macrophages and synovial fibroblasts, which leads to persistent inflammation and bone degradation, two of the major pathological processes in rheumatoid arthritis (RA). The aim of this study was to evaluate the association of MIF promoter polymorphisms (−794CATT5‐8 rs5844572 and −173G > C, rs755622), circulating MIF levels, and mRNA expression with RA susceptibility and disease activity.Methods: A case–control study was conducted in 200 RA patients and 200 control subjects (CS) from Southern Mexico. Genotyping was performed by conventional PCR and PCR‐RFLP methods. MIF mRNA expression was quantified by real‐time PCR and MIF serum levels were determined by an ELISA kit.Results: The 7,7 (−794CATT5‐8) and −173CC (−173G > C) genotypes were associated with higher disease activity in RA patients. MIF serum levels were increased, and MIF mRNA expression was reduced in RA patients as compared to CS. In addition, RA patients with moderate disease activity had higher MIF levels than those with low disease activity. The −794CATT5‐8 and −173G > C MIF polymorphisms were not associated with RA susceptibility.Conclusion: These results suggest an important role of MIF polymorphisms and MIF serum levels with disease activity in RA.

5 March 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
GSGabriela Athziri Sánchez-Zuno
Gabriela Athziri Sánchez-Zuno
MFMónica Matuz Flores
Mónica Matuz Flores
Cristian Oswaldo Hernández-RamírezCristian Oswaldo Hernández-Ramírez
Cristian Oswaldo Hernández-Ramírez
SPSaúl Alberto Díaz Pérez
Saúl Alberto Díaz Pérez
JHJorge Hernández-Bello
Jorge Hernández-Bello
Several studies have reported the benefits and safety of heterologous vaccination among different approved vaccines; however, there are no specific reports on the effects of vaccination with the Ad5-nCoV and other vaccines of the same or different technologies. In the present study, we evaluated the neutralizing antibodies percentage against SARS-CoV-2 in Mexican patients immunized with the Ad5-nCoV vaccine six months after its application. Moreover, the effect of the heterologous vaccination with the Ad5-nCoV vaccine and a booster dose of ChAdOx1-S-Nov-19, Ad26.COV2.S, BNT162b2, or mRNA-127 were determined. Our results suggest that a heterologous regimen of one dose with Ad5-nCoV vaccine followed by a booster dose of a different vaccine is safe and induces a stronger humoral immune response.

Verified
Journal Article
Open access
PDF file
ESEric Genaro Salmerón
Eric Genaro Salmerón
AZAndrea Martinez Zayas
Andrea Martinez Zayas
MVMiguel VARGAS
Miguel VARGAS
NVNicolás Villegas-Sepúlveda
Nicolás Villegas-Sepúlveda
PDPaola Briseño Diaz
Paola Briseño Diaz
RHRosaura Hernández-Rivas
Rosaura Hernández-Rivas
Genomic DNA methylation is an epigenetic modification that primarily occurs at CpG sites and is associated with the transcriptional repression of genes. This process plays a crucial role in maintaining cellular homeostasis and is catalyzed by a family of enzymes known as DNA methyltransferases (DNMTs), which includes DNMT1, DNMT2, DNMT3A, DNMT3B, and DNMT3L. DNMT1 is classified as a maintenance methyltransferase, whereas DNMT3A and DNMT3B are responsible for de novo methylation. Altered expression of DNMTs has been reported in various human diseases, including cancer. Cancer remains a major global health issue, with an estimated 20 million new cases and 9.7 million deaths reported in 2022. Among women, cervical cancer (CC) ranks fourth in both incidence and mortality worldwide, with persistent infection by high-risk human papillomavirus (HR-HPV) being the primary risk factor. Several studies have demonstrated that DNMT expression and activity are upregulated in CC, suggesting their potential as diagnostic and prognostic biomarkers. HR-HPV infection appears to increase DNMT expression, thereby promoting cervical carcinogenesis through aberrant methylation and subsequent silencing of tumor-suppressor genes such as PTEN, PAX1, and TSLC1. Furthermore, DNMTs are being explored as therapeutic targets in CC. In this review, we summarize the current state of the art regarding DNMTs in cervical cancer and discuss their functional roles and potential utility as diagnostic, prognostic, and therapeutic biomarkers.